Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 38.60
+0.60 (1.58%)
Jul 15, 2026, 4:25 PM CET
Gentian Diagnostics ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 182.12 | 176.5 | 152.07 | 135.15 | 111.92 | 100.01 | |
Revenue Growth (YoY) | 11.47% | 16.06% | 12.52% | 20.76% | 11.91% | 26.78% |
Cost of Revenue | 81.02 | 78.3 | 69.25 | 70.91 | 52.64 | 43.18 |
Gross Profit | 101.1 | 98.2 | 82.82 | 64.25 | 59.29 | 56.83 |
Selling, General & Admin | 53.59 | 54.33 | 49.78 | 48.12 | 40.91 | 39.54 |
Depreciation & Amortization Expenses | - | - | - | - | 10.24 | 7.35 |
Research & Development | 59.03 | 23.16 | 21.92 | 36.08 | - | - |
Other Operating Expenses | - | - | - | - | 31.37 | 32.79 |
Total Operating Expenses | 112.62 | 77.5 | 71.69 | 84.2 | 82.52 | 79.68 |
Operating Income | -7.34 | 25.45 | 15.72 | -12.76 | -23.24 | -22.85 |
Interest Income | 7.67 | 5.43 | 6.86 | 5.81 | 3.83 | 2.08 |
Interest Expense | -5.35 | -5.22 | -2.52 | -3.41 | -4.21 | -4.03 |
Other Non-Operating Income (Expense) | 4.18 | 4.75 | 4.6 | 7.19 | - | - |
Total Non-Operating Income (Expense) | 6.5 | 4.97 | 8.94 | 9.59 | -0.38 | -1.95 |
Pretax Income | -5.02 | 25.67 | 20.06 | -10.37 | -23.62 | -24.79 |
Provision for Income Taxes | 3.39 | 12.41 | -25.23 | 0.28 | - | - |
Net Income | -8.41 | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 |
Net Income to Common | -8.41 | 13.26 | 45.29 | -10.65 | -23.62 | -24.79 |
Net Income Growth | - | -70.73% | - | - | - | - |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 16 | 15 | 16 | 16 |
Shares Change (YoY) | -1.99% | -1.73% | 2.21% | -5.87% | 1.41% | 0.97% |
EPS (Basic) | -0.55 | 0.86 | 2.94 | -0.69 | -1.53 | -1.61 |
EPS (Diluted) | -0.55 | 0.86 | 2.87 | -0.69 | -1.53 | -1.61 |
EPS Growth | - | -70.03% | - | - | - | - |
Free Cash Flow | 18.27 | 41.38 | 12.08 | 14.5 | -22.59 | -28.08 |
Free Cash Flow Growth | -55.85% | 242.57% | -16.71% | - | - | - |
Free Cash Flow Per Share | 1.18 | 2.67 | 0.77 | 0.94 | -1.38 | -1.74 |
Dividends Per Share | 0.600 | 0.600 | 0.400 | - | - | - |
Dividend Growth | - | 50.00% | - | - | - | - |
Gross Margin | 55.51% | 55.64% | 54.46% | 47.54% | 52.97% | 56.83% |
Operating Margin | -4.03% | 14.42% | 10.34% | -9.44% | -20.76% | -22.84% |
Profit Margin | -4.62% | 7.51% | 29.78% | -7.88% | -21.10% | -24.79% |
FCF Margin | 10.03% | 23.45% | 7.94% | 10.73% | -20.18% | -28.07% |
EBITDA | 1.71 | 34.57 | 24.69 | -3.2 | -12.99 | -15.5 |
EBITDA Margin | 0.94% | 19.58% | 16.23% | -2.36% | -11.61% | -15.49% |
EBIT | -7.34 | 25.45 | 15.72 | -12.76 | -23.24 | -22.85 |
EBIT Margin | -4.03% | 14.42% | 10.34% | -9.44% | -20.76% | -22.84% |
Effective Tax Rate | -67.58% | 48.35% | -125.74% | -2.72% | 0.00% | 0.00% |